These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3710704)

  • 1. 99mTc bone scanning agents--III. Preparation and gel chromatography of 99mTc(Sn)MDP complexes.
    Kroesbergen J; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):419-24. PubMed ID: 3710704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc bone scanning agents--V. Influence of experimental conditions on the labeling efficiency and gel chromatography of 99mTc(Sn)HMDP.
    Kroesbergen J; Wortelboer MR; Rijnsent A; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum B; 1987; 14(1):37-41. PubMed ID: 3583753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc bone scanning agents--I. Influence of experimental conditions on the formation and gel chromatography of 99mTc(Sn)pyrophosphate complexes.
    Kroesbergen J; Gelsema WJ; De Ligny CL
    Int J Nucl Med Biol; 1985; 12(2):83-8. PubMed ID: 2995268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pH on the formation of Tc(NaBH4)-MDP radiopharmaceutical analogues.
    Tanabe S; Zodda JP; Deutsch E; Heineman WR
    Int J Appl Radiat Isot; 1983 Dec; 34(12):1577-84. PubMed ID: 6230322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc bone scanning agents--IV. Chemical characterization of 99mTc(Sn)-pyrophosphate complexes.
    Kroesbergen J; Roozen AM; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum B; 1988; 15(2):209-14. PubMed ID: 3366621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantitative whole-body bone scintigraphy. II. Pharmacokinetics of osteotropic radiopharmaceuticals (author's transl)].
    Anger K; Aigner S; Bühler M; Umbach I
    Nuklearmedizin; 1980 Jul; 19(3):97-107. PubMed ID: 7465432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
    Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversed-phase HPLC of 99mTc methylene diphosphonate bone imaging kits with quantification of pertechnetate.
    Hoch DJ; Pinkerton TC
    Int J Rad Appl Instrum A; 1986; 37(7):593-8. PubMed ID: 3021661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophoretic analysis of different technetium-99m (SnCl2) methylene diphosphonate complexes.
    Najafi A; Hutchison N
    J Nucl Med; 1985 May; 26(5):524-30. PubMed ID: 3157787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of Sn(IV) on the mean size of 99mTc(Sn)MDP constituents at neutral pH.
    Gelsema WJ; de Ligny CL; Tji TG
    Int J Rad Appl Instrum A; 1987; 38(4):251-4. PubMed ID: 3040628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of 99mTc(113Sn)-MDP to human serum albumin. The influence of various technetium, tin, and MDP concentrations.
    Grouls RJ; Oldenburg SJ; Savelkoul TJ; Dröge JH
    Int J Rad Appl Instrum B; 1987; 14(2):127-32. PubMed ID: 3597113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc bone scanning agents--VI. Gel chromatographic analysis of the plasma protein binding of 99mTc(Sn)pyrophosphate, 99mTc(Sn)MDP and 99mTc(Sn)HMDP.
    Kroesbergen J; Roozen AM; Wortelboer MR; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum B; 1988; 15(5):479-87. PubMed ID: 3254872
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bayesian analysis of myocardial scintigraphy using 99mTc-Sn(II)-methylenediphosphonate and using 99mTc-Sn(II)-pyrophosphate].
    Cuarón A; Acero A; Cárdenas M
    Arch Inst Cardiol Mex; 1982; 52(5):365-72. PubMed ID: 7149857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A micro-autoradiographical study of the localization of 99mTc(Sn)-MDP and 99mTc-MDP in undecalcified bone sections.
    Savelkoul TJ; Visser WJ; Oldenburg SJ; Duursma SA
    Eur J Nucl Med; 1986; 11(11):459-62. PubMed ID: 3086099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of radiochemical purity of 99mTc(Sn)-methylene diphosphonate using gel chromatography].
    Vucina JL
    Med Pregl; 1995; 48(3-4):95-7. PubMed ID: 8657075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anion exchange chromatography of 99mTc(Sn)-MDP complexes: influence of eluent composition, determination of void volume and charge of the main component.
    Huigen YM; Tji TG; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum A; 1988; 39(1):25-30. PubMed ID: 2828279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the parameters related to the formation of 99mTc-pyrophosphate complexes using gel chromatography column scanning.
    Shafiq YF; Al-Janabi MA; Al-Azzawi HM; Abdel-Azeez MA; Al-Hissoni MH; Jassim MN
    Nuklearmedizin; 1985 Jun; 24(3):146-9. PubMed ID: 2997754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gel chromatographic analysis of the bone seeking radiopharmaceutical 99mTc(Sn)-EHDP: the influence of pH and EHDP-concentration on the size of its constituents.
    Huigen YM; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum A; 1987; 38(8):615-8. PubMed ID: 2822619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrolytically labeled [99mTc]MDP: chromatographic pattern, stability and biodistribution in rats.
    Savelkoul TJ; Oldenburg SJ; Van Oort WJ; Duursma SA
    Int J Appl Radiat Isot; 1984 Aug; 35(8):709-13. PubMed ID: 6237064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution of anionic separated MDP complexes from different MDP preparations.
    Handeland A; Lindegaard MW; Heggli DE
    Eur J Nucl Med; 1989; 15(9):609-11. PubMed ID: 2598957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.